Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder

키워드

참고문헌 (42)

1. Castren E, "Role of neurotrophic factors in depression", Curr Opin Pharmacol, 7, pp.18~21 (2007)[DOI]
2. Warner-Schmidt JL, "Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment", Hippocampus, 16, pp.239~249 (2006)[DOI]
3. Ducray A, "GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon", Brain Res, 1069, pp.104~112 (2006)[DOI]
4. Pittenger C, "Stress, depression, and neuroplasticity: a convergence of mechanisms", Neuropsychopharmacology, 33, pp.88~109 (2008)[DOI]
5. Tsankova NM, "Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action", Nat Neurosci, 9, pp.519~525 (2006)[DOI]
6. Sen S, "Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications", Biol Psychiatry, 64, pp.527~532 (2008)[DOI]
7. Molendijk ML, "Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (n=9484)", Mol Psychiatry, 19, pp.791~800 (2014)[DOI]
8. Yoshimura R, "Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.1034~1037 (2007)[DOI]
9. Lee HY, "Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants", Neuropsychobiology, 57, pp.194~199 (2008)[DOI]
10. Elfving B, "Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level", J Psychiatr Res, 46, pp.1118~1125 (2012)[DOI]
11. Groves JO, "Is it time to reassess the BDNF hypothesis of depression?", Mol Psychiatry, 12, pp.1079~1088 (2007)[DOI]
12. Airaksinen MS, "The GDNF family: signalling, biological functions and therapeutic value", Nat Rev Neurosci, 3, pp.383~394 (2002)[DOI]
13. Tang YP, "Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments", J Neurosci Res, 53, pp.593~604 (1998)[DOI]
14. Lin PY, "Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study", J Psychiatr Res, 63, pp.20~27 (2015)[DOI]
15. Michel TM, "Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study", Eur Psychiatry, 23, pp.413~420 (2008)[DOI]
16. Wang X, "Association study between plasma GDNF and cognitive function in late-onset depression", J Affect Disord, 132, pp.418~421 (2011)[DOI]
17. Bian Y, "Learning, memory, and glial cell changes following recovery from chronic unpredictable stress", Brain Res Bull, 88, pp.471~476 (2012)[DOI]
18. Gupta R, "Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-<TEX>${\alpha}$<", TEX> in patients of major depressive disorder with severe depression, 2016, pp.97, 184~188
19. Fornaro M, "BDNF plasma levels variations in major depressed patients receiving duloxetine", Neurol Sci, 36, pp.729~734 (2015)[DOI]
20. Ladea M, "Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram", Psychiatr Danub, 25, pp.128~132 (2013)
21. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)[DOI]
22. Zimmerman M, "Severity classification on the Hamilton Depression Rating Scale", J Affect Disord, 150, pp.384~388 (2013)[DOI]
23. Maier W, "The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders", J Affect Disord, 14, pp.61~68 (1988)[DOI]
24. Riedel M, "Response and remission criteria in major depression--a validation of current practice", J Psychiatr Res, 44, pp.1063~1068 (2010)[DOI]
25. Polyakova M, "BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis", J Affect Disord, 174, pp.432~440 (2015)[DOI]
26. Lee BH, "Decreased plasma BDNF level in depressive patients", J Affect Disord, 101, pp.239~244 (2007)[DOI]
27. Kheirouri S, "Elevated brain-derived neurotrophic factor correlates negatively with severity and duration of major depressive episodes", Cogn Behav Neurol, 29, pp.24~31 (2016)[DOI]
28. Papakostas GI, "Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study", Mol Psychiatry, 18, pp.332~339 (2013)[DOI]
29. Blugeot A, "Vulnerability to depression: from brain neuroplasticity to identification of biomarkers", J Neurosci, 31, pp.12889~12899 (2011)[DOI]
30. Luo KR, "Differential regulation of neurotrophin S100B and BDNF in two rat models of depression", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.1433~1439 (2010)[DOI]
31. Larsen MH, "Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment", J Psychiatr Res, 44, pp.808~816 (2010)[DOI]
32. Krishnan V, "The molecular neurobiology of depression", Nature, 455, pp.894~902 (2008)[DOI]
33. Mikoteit T, "High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression", Psychopharmacology (Berl), 231, pp.2955~2965 (2014)[DOI]
34. Zhang X, "Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.886~890 (2008)[DOI]
35. Zhang X, "Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression", Psychiatry Res, 170, pp.273~275 (2009)[DOI]
36. Sun H, "Effects of electroacupuncture on depression and the production of glial cell line-derived neurotrophic factor compared with fluoxetine: a randomized controlled pilot study", J Altern Complement Med, 19, pp.733~739 (2013)[DOI]
37. Brunoni AR, "Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis", Prog Neuropsychopharmacol Biol Psychiatry, 56, pp.91~96 (2015)[DOI]
38. Lee BH, "Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: a preliminary study", Acta Neuropsychiatr, 28, pp.45~50 (2016)[DOI]
39. Cheng H, "Ability of GDNF to diminish free radical production leads to protection against kainate-induced excitotoxicity in hippocampus", Hippocampus, 14, pp.77~86 (2004)[DOI]
40. Choi SW, "Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects", Psychiatry Res, 186, pp.427~430 (2011)[DOI]
41. Lee BH, "Psychotropic drugs on in vitro brain-derived neurotrophic factor production in whole blood cell cultures from healthy subjects", J Clin Psychopharmacol, 30, pp.623~627 (2010)[DOI]
42. Bun-Hee Lee, "The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment", PSYCHIATRY INVESTIGATION, 7(4), pp.231~235 (2010), 대한신경정신의학회

관련 논문AI추천